Skip to content

Beneficient BENF Maturities of convertible senior notes

Maturities of convertible senior notes at other companies

Silvaco Group, Inc. logo
Silvaco Group, Inc.SVCO
$0-100%
HTF
Heartflow, Inc. Common StockHTFL
$73.86M
Cineverse Corp. logo
Cineverse Corp.CNVS
$3.25M
Bit Digital logo
Bit DigitalBTBT
$222.12M+518%
Beneficient logo
BeneficientBENF
$0-100%
Ondas, Inc.
 logo
Ondas, Inc. ONDS
$923K

Other financials

Income statement

See full
Revenue$18.7M+322%
Operating income$3.9M+141%
Net income$19.9M+331%
EPS (diluted)-$0.49+26.5%

Balance sheet

See full
Cash & equivalents$7.9M+87.3%
Total debt$100.3M-16.6%
Total equity-$128.6M-1,002%
Total assets$337.9M-15.5%

Cash flow

See full
Operating cash flow-$9.4M+6.3%
CapEx$96.0K-85.5%
Free cash flow-$9.4M+6.7%

Valuation

See full
Market cap$52.86M+2,018%
Enterprise value$145.33M+40.6%

Profitability

See full
Operating margin548.5%-323pp
Net margin517.9%-235pp
FCF margin156.8%-40.4pp

Returns & leverage

See full
Return on equity-1,647.1%-2,080pp
Debt / equity8.4×-23.8×

Where this comes from

Reported directly by Beneficient in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromConvertibleDebt.

The official record: Beneficient’s 10-Q, filed February 17, 2026, on SEC EDGAR. View the filing →

Ask your AI about Beneficient's maturities of convertible senior notes.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Beneficient's maturities of convertible senior notes?
Beneficient (BENF) reported maturities of convertible senior notes of $0 in Q4 2025.
What does maturities of convertible senior notes mean?
Reflects the cash inflows generated from the issuance of debt instruments that can be converted into equity shares. This serves as a strategic financing tool to raise capital while potentially reducing future interest burdens if conversion occurs. It is a key indicator of the company's ability to access capital markets through hybrid financial instruments.